November 29, 2022

The Latest News in Topicals for Psoriasis

Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals – Tapinarof and Roflumilast, could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center, in Rockville, M.D.

This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb, and Janssen.

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.